Artificial intelligence using a latent diffusion model enables the generation of diverse and potent antimicrobial peptides.

Journal: Science advances
PMID:

Abstract

Artificial intelligence holds great promise for the design of antimicrobial peptides (AMPs); however, current models face limitations in generating AMPs with sufficient novelty and diversity, and they are rarely applied to the generation of antifungal peptides. Here, we develop an alternative pipeline grounded in a diffusion model and molecular dynamics for the de novo design of AMPs. The peptides generated by our pipeline have lower similarity and identity than those of other reported methodologies. Among the 40 peptides synthesized for an experimental validation, 25 exhibit either antibacterial or antifungal activity. AMP-29 shows selective antifungal activity against and in vivo antifungal efficacy in a murine skin infection model. AMP-24 exhibits potent in vitro activity against Gram-negative bacteria and in vivo efficacy against both skin and lung infection models. The proposed approach offers a pipeline for designing diverse AMPs to counteract the threat of antibiotic resistance.

Authors

  • Yeji Wang
    Xiangya International Academy of Translational Medicine, Central South University, Changsha, Hunan 410013, China.
  • Minghui Song
    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China.
  • Fujing Liu
    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China.
  • Zhen Liang
    Graduate School of Informatics, Kyoto University, Kyoto 606-8501, Japan; School of Biomedical Engineering, Health Science Center, Shenzhen University, Shenzhen, 518060, China. Electronic address: jane-l@sys.i.kyoto-u.ac.jp.
  • Rui Hong
    Radiology, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Yuemei Dong
    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China.
  • Huaizu Luan
    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China.
  • Xiaojie Fu
    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China.
  • Wenchang Yuan
    Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Wenjie Fang
    Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China.
  • Gang Li
    The Centre for Cyber Resilience and Trust, Deakin University, Australia.
  • Hongxiang Lou
    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China.
  • Wenqiang Chang
    Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China.